|
Volumn 294, Issue 5544, 2001, Pages 985-
|
Smallpox vaccinations: How much protection remains?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SMALLPOX VACCINE;
VIRUS ANTIBODY;
VACCINATION;
ADOLESCENT;
ADULT;
AGED;
CELLULAR IMMUNITY;
CHILD;
DATA BASE;
HUMAN;
IMMUNIZATION;
IMMUNOLOGICAL MEMORY;
INFANT;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
SHORT SURVEY;
SMALLPOX;
T LYMPHOCYTE;
UNITED KINGDOM;
UNITED STATES;
VACCINATION;
VIRUS INFECTION;
ARTICLE;
BIOLOGICAL WARFARE;
BLOOD;
EPIDEMIC;
IMMUNOLOGY;
SMALLPOX VIRUS;
TIME;
VACCINIA VIRUS;
ANTIBODIES, VIRAL;
BIOTERRORISM;
DISEASE OUTBREAKS;
HUMANS;
IMMUNOLOGIC MEMORY;
SMALLPOX;
SMALLPOX VACCINE;
T-LYMPHOCYTES;
TIME FACTORS;
VACCINATION;
VACCINIA VIRUS;
VARIOLA VIRUS;
|
EID: 0035798182
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.294.5544.985 Document Type: Short Survey |
Times cited : (57)
|
References (0)
|